These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15044223)

  • 41. [Toxicity of antitubercular agents for the liver].
    Dölle W
    Dtsch Med Wochenschr; 1973 Jan; 98(2):74. PubMed ID: 4683834
    [No Abstract]   [Full Text] [Related]  

  • 42. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
    Can Commun Dis Rep; 2001 Jul; 27(13):114-6. PubMed ID: 11443837
    [No Abstract]   [Full Text] [Related]  

  • 43. Pyrazinamide-induced lichenoid photodermatitis.
    Choonhakarn C; Janma J
    J Am Acad Dermatol; 1999 Apr; 40(4):645-6. PubMed ID: 10188694
    [No Abstract]   [Full Text] [Related]  

  • 44. Safety and completion rate of short-course therapy for treatment of latent tuberculosis infection.
    Cook PP; Maldonado RA; Yarnell CT; Holbert D
    Clin Infect Dis; 2006 Aug; 43(3):271-5. PubMed ID: 16804838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.
    Tostmann A; Boeree MJ; Aarnoutse RE; de Lange WC; van der Ven AJ; Dekhuijzen R
    J Gastroenterol Hepatol; 2008 Feb; 23(2):192-202. PubMed ID: 17995946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of tuberculous meningitis complicated with multiple drug hypersensitivity to antituberculosis agents].
    Arai M
    Rinsho Shinkeigaku; 2015; 55(2):123-5. PubMed ID: 25746078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Side effects of antituberculosis therapy.
    Leung CC; Chan CK; Yew WW
    Am J Respir Crit Care Med; 2004 May; 169(10):1168-9; author reply 1169. PubMed ID: 15132966
    [No Abstract]   [Full Text] [Related]  

  • 48. [The interest of addiction to first line anti-TB drugs].
    Aniked S; Bakouh O; Bourkadi JE
    Pan Afr Med J; 2014; 19():207. PubMed ID: 25821550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Oral desensitization to antitubercular agents].
    Drira I; Souissi R; Dakhlaoui R; Jeguirim MS; Chebbi ML
    Rev Pneumol Clin; 1997; 53(2):104-6. PubMed ID: 9205691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cutaneous reaction after pyrazinamide initiation].
    Mulliez P; Mbassi Fouda FL; Roy Saint-Georges F
    Med Mal Infect; 2011 Sep; 41(9):499-500. PubMed ID: 21458177
    [No Abstract]   [Full Text] [Related]  

  • 51. Antituberculosis drug-induced hepatitis--the dangers of rechallenge.
    Monteagudo FS; Pillans PI
    S Afr Med J; 1986 Sep; 70(7):437-8. PubMed ID: 3764619
    [No Abstract]   [Full Text] [Related]  

  • 52. [Medication-induced hepatic lesions in patients with pulmonary tuberculosis].
    Gned'ko NI
    Voen Med Zh; 2002 May; 323(5):56-8. PubMed ID: 12073843
    [No Abstract]   [Full Text] [Related]  

  • 53. [Characteristics of drug-induced hepatitis in patients with tuberculosis].
    Vil'derman AM
    Probl Tuberk; 1972; 50(5):59-63. PubMed ID: 4112966
    [No Abstract]   [Full Text] [Related]  

  • 54. [Centrilobular liver necrosis following antimycobacterial treatment].
    Beckert W
    Z Erkr Atmungsorgane Folia Bronchol; 1971 Aug; 135(1):11-7. PubMed ID: 5209484
    [No Abstract]   [Full Text] [Related]  

  • 55. Antituberculosis therapy drug-induced liver injury and acute liver failure.
    Devarbhavi H; Dierkhising R; Kremers WK
    Hepatology; 2010 Aug; 52(2):798-9; author reply 799-800. PubMed ID: 20683973
    [No Abstract]   [Full Text] [Related]  

  • 56. [A study of 172 patients with hepatic injury caused by antituberculosis drugs].
    Cheng SQ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):571. PubMed ID: 15387923
    [No Abstract]   [Full Text] [Related]  

  • 57. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
    Yee D; Valiquette C; Pelletier M; Parisien I; Rocher I; Menzies D
    Am J Respir Crit Care Med; 2003 Jun; 167(11):1472-7. PubMed ID: 12569078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatotoxicity to different antituberculosis drug combinations.
    Aziz S; Agha F; Hassan R; Fairoz SA; Hassan K
    J Pak Med Assoc; 1990 Dec; 40(12):290-4. PubMed ID: 2126569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Liver toxicity of aetina and pyracinamide and their control by determination of LAP activity in blood serum].
    Matzel W; Lindemann I
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 131(1):87-98. PubMed ID: 5197904
    [No Abstract]   [Full Text] [Related]  

  • 60. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
    Tiwari VK
    J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.